A detailed history of Advisor Net Financial, Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Net Financial, Inc holds 12 shares of ACAD stock, worth $204. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$204
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$15.14 - $19.14 $181 - $229
12 New
12 $0
Q1 2021

Apr 14, 2021

SELL
$25.02 - $54.99 $2,752 - $6,048
-110 Reduced 12.94%
740 $19,000
Q4 2020

Feb 04, 2021

BUY
$41.04 - $56.79 $4,514 - $6,246
110 Added 14.86%
850 $45,000
Q4 2019

Feb 12, 2020

SELL
$36.21 - $51.4 $869 - $1,233
-24 Reduced 3.14%
740 $32,000
Q3 2019

Oct 23, 2019

BUY
$22.22 - $44.01 $16,976 - $33,623
764 New
764 $27,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.